Edition:
United Kingdom

Express Scripts Holding Co (ESRX.OQ)

ESRX.OQ on NASDAQ Stock Exchange Global Select Market

97.64USD
16 Nov 2018
Change (% chg)

$0.18 (+0.18%)
Prev Close
$97.46
Open
$97.23
Day's High
$98.11
Day's Low
$97.23
Volume
1,422,523
Avg. Vol
1,255,333
52-wk High
$100.43
52-wk Low
$60.63

Latest Key Developments (Source: Significant Developments)

Cigna CEO Says Continues To Expect To Close Express Scripts Deal By End Of The Year
Thursday, 1 Nov 2018 

Nov 1 (Reuters) - Cigna Corp ::CEO SAYS EXPRESS SCRIPTS <<>> DEAL HAS GAINED REGULATORY APPROVAL ACROSS 23 STATES, WITH 6 APPROVALS REMAINING - CONF CALL.CEO SAYS CO CONTINUES TO EXPECT TO CLOSE EXPRESS SCRIPTS DEAL BY THE END OF THE YEAR - CONF CALL.CIGNA CEO SAYS MARGINS IN U.S. INDIVIDUAL BUSINESS WERE HIGHER THAN ANTICIPATED THIS YEAR BUT LIKELY TO BE "MORE IN LINE" WITH EXPECTATIONS IN 2019.CIGNA SAYS FOR NOW 2021 ADJUSTED. EPS TARGET REMAINS IN THE RANGE OF $20-$21.  Full Article

Teva Pharm CEO comments to Reuters
Thursday, 1 Nov 2018 

Nov 1 (Reuters) - Teva Pharmaceutical Industries Ltd , TEVA.N::TEVA PHARM CEO SAYS TO LAUNCH GENERIC EPIPEN IN U.S. MARKET IN FOURTH QUARTER.TEVA PHARM CEO: TALKS ONGOING WITH ALL U.S. PAYERS INCLUDING EXPRESS SCRIPTS ON AJOVY MIGRAINE DRUG.TEVA PHARM CEO TO REUTERS: 2019 FULL YEAR REVENUES TO BE BELOW 2018 IN A "TROUGH YEAR".TEVA PHARM CEO: CONVINCED MIGRAINE DRUG MARKET WILL BE "LARGE AND ATTRACTIVE" FOR US AND COMPETITORS.  Full Article

Express Scripts Q3 Adjusted Earnings Per Share $2.43
Wednesday, 31 Oct 2018 

Oct 31 (Reuters) - Express Scripts Holding Co ::EXPRESS SCRIPTS ANNOUNCES 2018 THIRD QUARTER RESULTS.Q3 ADJUSTED EARNINGS PER SHARE $2.43.Q3 GAAP EARNINGS PER SHARE $1.89.Q3 EARNINGS PER SHARE VIEW $2.43 -- THOMSON REUTERS I/B/E/S.QTRLY REVENUE $25,563.2 MILLION VERSUS $24,683.4 MILLION REPORTED LAST YEAR.QTRLY ADJUSTED CLAIMS OF 334.6 MILLION, DOWN 2.6%.EXPECTS 2019 RETENTION RATE FOR 2018 SELLING SEASON TO EXCEED 98%.EXPECT TO GROW CORE BUSINESS ADJUSTED CLAIMS BY 2% TO 3% IN 2019.Q3 REVENUE VIEW $25.04 BILLION -- THOMSON REUTERS I/B/E/S.CIGNA MERGER IS EXPECTED TO BE COMPLETED BY DECEMBER 31, 2018.EXPRESS SCRIPTS - DUE TO PENDING ACQUISITION BY CIGNA, WILL NOT BE HOLDING A Q3 CONFERENCE, WILL NO LONGER PROVIDE FINANCIAL GUIDANCE.  Full Article

Cigna Announces Enterprise Leadership Team For Combined Company
Thursday, 27 Sep 2018 

Sept 27 (Reuters) - Cigna Corp ::CIGNA ANNOUNCES ENTERPRISE LEADERSHIP TEAM FOR COMBINED COMPANY.EXPRESS SCRIPTS PRESIDENT AND CEO TIM WENTWORTH WILL HEAD HEALTH SERVICES BUSINESS AS PRESIDENT, EXPRESS SCRIPTS AND CIGNA SERVICES.ERIC PALMER WILL BE THE CHIEF FINANCIAL OFFICER OF THE COMBINED CO AFTER EXPRESS SCRIPTS MERGER.CHANGES EFFECTIVE UPON COMPLETION OF EXPRESS SCRIPTS MERGER, EXPECTED BY YEAR-END 2018.COMBINED CO WILL OFFER PLATFORMS SUCH AS A COMMERCIAL BUSINESS, A GOVERNMENT. BUSINESS, INTERNATIONAL BUSINESS & A HEALTH SERVICES BUSINESS.COMBINED CO'S HEALTH SERVICES BUSINESS WILL INCLUDE EXPRESS SCRIPTS.  Full Article

Express Scripts Reports Q2 Adjusted Earnings Per Share Of $2.22
Wednesday, 1 Aug 2018 

Aug 1 (Reuters) - Express Scripts Holding Co ::PROJECTS 2% TO 3% CORE ADJUSTED CLAIMS GROWTH FOR 2019.EXPRESS SCRIPTS ANNOUNCES 2018 SECOND QUARTER RESULTS.Q2 ADJUSTED EARNINGS PER SHARE $2.22.Q2 GAAP EARNINGS PER SHARE $1.55.SEES Q3 2018 ADJUSTED EARNINGS PER SHARE $2.40 TO $2.45.Q2 EARNINGS PER SHARE VIEW $2.20 -- THOMSON REUTERS I/B/E/S.QTRLY ADJUSTED CLAIMS OF 337.9 MILLION, DOWN 3.5%.QTRLY REVENUE $25,641.8 MILLION VERSUS $25,347.5 MILLION REPORTED LAST YEAR.UPDATING EXPECTED 2019 RETENTION RATE FOR 2018 SELLING SEASON TO A RANGE OF 97.5% TO 98.5%.COMPANY INCREASED ITS CORE BUSINESS 2018 ADJUSTED EBITDA GUIDANCE TO A RANGE OF $5,275 MILLION TO $5,425 MILLION.EXPECTS TOTAL ADJUSTED CLAIMS FOR Q3 2018 TO BE IN THE RANGE OF 330 MILLION TO 340 MILLION.EXPRESS SCRIPTS HOLDING - SEES CONSOLIDATED ADJUSTED EARNINGS PER SHARE FOR Q3 2018 TO BE IN THE RANGE OF $2.40 TO $2.45.SEES FY 2018 REVENUE $99,000 MILLION TO $102,000 MILLION.SEES FY 2018 ADJUSTED EARNINGS PER DILUTED SHARE $9.00 TO $9.14.INCREASED CORE BUSINESS 2018 ADJUSTED EBITDA GUIDANCE TO A RANGE OF $5,275 MILLION TO $5,425 MILLION.  Full Article

Cigna-On April 23, Co, Express Scripts Each Received Request For Additional Info, Documentary Material From DOJ In Connection With DOJ's Review Of Deal
Monday, 23 Apr 2018 

April 23 (Reuters) - Cigna Corp ::CIGNA-ON APRIL 23, CO, EXPRESS SCRIPTS EACH RECEIVED REQUEST FOR ADDITIONAL INFO, DOCUMENTARY MATERIAL FROM DOJ IN CONNECTION WITH DOJ'S REVIEW OF DEAL.CIGNA - EFFECT OF SECOND REQUEST IS TO EXTEND WAITING PERIOD IMPOSED BY HART-SCOTT-RODINO ACT UNTIL 30 DAYS AFTER CO, EXPRESS SCRIPTS HAVE COMPLIED WITH SECOND REQUEST.  Full Article

Express Scripts Holding Sees FY 2017 ADJ SHR $7.00 To $7.08
Thursday, 14 Dec 2017 

Dec 14 (Reuters) - Express Scripts Holding Co ::EXPRESS SCRIPTS HOLDING COMPANY UPDATES 2017 FULL-YEAR GUIDANCE AND ANNOUNCES 2018 FINANCIAL GUIDANCE.SEES FY 2018 ADJUSTED EARNINGS PER SHARE $7.67 TO $7.87.SEES FY 2017 ADJUSTED EARNINGS PER SHARE $7.00 TO $7.08.EXPECTS 2017 FULL-YEAR TOTAL ADJUSTED CLAIMS FOR ITS CORE BUSINESS TO BE IN RANGE OF 1,158 MILLION TO 1,172 MILLION.NARROWED PREVIOUSLY ISSUED CONSOLIDATED 2017 ADJUSTED EBITDA GUIDANCE TO A RANGE OF $7,370 MILLION TO $7,450 MILLION.ESTIMATE THAT EVICORE ACQUISITION WILL GENERATE EBITDA OF $265 MILLION TO $285 MILLION IN 2018.EVICORE ACQUISITION AND SALE OF UNITED BIOSOURCE ARE EXPECTED TO BE COMPLETED IN DECEMBER 2017.ENTERPRISE VALUE INITIATIVE ESTIMATED TO COST ABOUT $600-$650 MILLION & TO DELIVER CUMULATIVE SAVINGS OF NEARLY $1.2 BILLION BY 2021.FY2017 EARNINGS PER SHARE VIEW $7.01 -- THOMSON REUTERS I/B/E/S.FY2018 EARNINGS PER SHARE VIEW $7.65 -- THOMSON REUTERS I/B/E/S.SEES CORE ESTIMATED REVENUE FOR 2018 OF $80,500 MILLION TO $83,000 MILLION.SEES CONSOLIDATED ESTIMATED REVENUE FOR 2018 OF $99,000 MILLION TO $102,000 MILLION.FY2018 REVENUE VIEW $101.29 BILLION -- THOMSON REUTERS I/B/E/S.COMPANY EXPECTS CORE 2017 FULL-YEAR ADJUSTED EBITDA GUIDANCE IN RANGE OF $4,910 MILLION TO $4,970 MILLION.SEES CORE ESTIMATED TOTAL ADJUSTED CLAIMS FOR 2018 OF 1,125 MILLION TO 1,165 MILLION.SEES CONSOLIDATED ESTIMATED TOTAL ADJUSTED CLAIMS FOR 2018 OF 1,345 MILLION TO 1,395 MILLION.  Full Article

Avista Capital Partners To Acquire Express Scripts' Subsidiary United Biosource
Monday, 27 Nov 2017 

Nov 27 (Reuters) - Express Scripts Holding Co ::AVISTA CAPITAL PARTNERS TO ACQUIRE EXPRESS SCRIPTS' SUBSIDIARY UNITED BIOSOURCE.AVISTA CAPITAL PARTNERS TO ACQUIRE EXPRESS SCRIPTS' SUBSIDIARY UNITED BIOSOURCE.EXPRESS SCRIPTS HOLDING CO - ‍AVISTA SIGNED DEFINITIVE AGREEMENT TO ACQUIRE UNITED BIOSOURCE, A SUBSIDIARY OF CO.  Full Article

Express Scripts appoints James Havel as CFO
Tuesday, 24 Oct 2017 

Oct 25 (Reuters) - Express Scripts Holding Co :Express Scripts Holding Co appoints James M. Havel chief financial officer.Express Scripts Holding Co - ‍Eric Slusser, executive vice president and chief financial officer, is leaving company​.  Full Article

Express Scripts reports Q3 GAAP earnings per share $1.46
Tuesday, 24 Oct 2017 

Oct 25 (Reuters) - Express Scripts Holding Co :Express Scripts announces 2017 third quarter results.Q3 adjusted earnings per share $1.90.Q3 GAAP earnings per share $1.46.Q3 earnings per share view $1.90 -- Thomson Reuters I/B/E/S.Sees Q4 2017 adjusted earnings per share $2.03 to $2.11.Express Scripts holding co qtrly ‍adjusted claims of 343.6 million, down 1 pct​.Qtrly ‍revenues $24,683 million versus $25,410 million.Express Scripts holding-‍increasing expected 2018 retention rate for 2017 selling season, excluding impact of remaining coventry business to be above 95 percent​.Says ‍company expects to formalize plan for its enterprise value initiative by end of 2017​.Express Scripts holding-‍enterprise value initiative estimated to cost about $600 million to $650 million ,to deliver cumulative savings of nearly $1.2 billion by 2021​.Express Scripts holding-‍increased its guidance for fy 2017 adjusted earnings per diluted share from a range of $6.95 to $7.05 to a range of $6.97 to $7.05​.Says ‍adjusted earnings per diluted share for q4 of 2017 is estimated to be in range of $2.03 to $2.11​.Express Scripts holding co says ‍expects total adjusted claims for q4 of 2017 to be in range of 347 million to 363 million​.Q4 earnings per share view $2.05 -- Thomson Reuters I/B/E/S.Fy2017 earnings per share view $6.99 -- Thomson Reuters I/B/E/S.  Full Article

Photo

Walmart, Home Depot adopt health insurer tactic in drug copay battle

NEW YORK Walmart and Home Depot , two of the top 10 U.S. employers, have embraced a health insurance strategy that punishes drugmakers for using discount cards to keep patients from switching or stopping their medications.